Paracetamol adducts following overdose treated with a shorter acetylcysteine infusion: findings from the NACSTOP 2 trial
Abstract
Introduction: Paracetamol protein adducts in the circulation are a specific biomarker of paracetamol oxidation, and a highly sensitive measure of potential hepatic injury following overdose. We performed an analytical sub-study of adducts during a clinical trial (NACSTOP2) of abbreviated (12 hour) versus control (20 hour) acetylcysteine to identify any signal of decreased antidotal effectiveness with shortened therapy.
Methods: We measured adducts from a convenience sample of subjects enrolled in the randomised-controlled NACSTOP2 trial evaluating a 12-hour ("abbreviated"; 200 mg/kg over four hours, 50 mg/kg over 8 hours) vs 20-hour acetylcysteine regimen ("control"; 200 mg/kg over four hours, 100 mg/kg over 16 hours). Adducts were assayed using high-performance liquid chromatography with electrochemical detection.
Results: The median alanine transaminase 20 hours after the initiation of acetylcysteine were 13 U/L (IQR 10-25 U/L) in the abbreviated 12-hour regimen group (n = 29), compared to the control group 14 U/L (IQR 10-19 U/L; n = 28) (P = 0.46). Adduct concentrations after 20 hours post initiation of acetylcysteine were similarly low in both groups: median 0.18 µmol/L, (IQR 0.09-0.24 µmol/L) to the control 0.17 µmol/L (IQR 0.11-0.27), P = 0.43.
Discussion: In both the NACSTOP and NACSTOP 2 trials, adduct concentrations remained low in this selected cohort of low risk patients, supporting abbreviation of the acetylcysteine regimen.
Conclusions: In selected low-risk…
How strong is the evidence?
Evidence Hub reads this as a randomized trial, done in people. Its evidence level is 3 of 5 (Moderate · trial / cohort / secondary analysis). Trials without a large randomized design, cohorts and secondary analyses give moderate evidence. Reported size: 29 participants or records.
Read the paper
Related studies
- Effect of dexamethasone as an analgesic adjuvant to multimodal pain treatment after total knee arthroplasty: randomised clinical trial
- Effect of a Postoperative Multimodal Opioid-Sparing Protocol vs Standard Opioid Prescribing on Postoperative Opioid Consumption After Knee or Shoulder Arthroscopy: A Randomized Clinical Trial
- Comparison of the Post-Caesarean Analgesic Effect of Adding Dexmedetomidine to Paracetamol and Ketorolac: A Randomized Clinical Trial
- A triple-blind randomized clinical trial of different associations between dexamethasone and non-steroids anti-inflammatories for preemptive action in third molar extractions
- An open label randomized clinical trial of Indomethacin for mild and moderate hospitalised Covid-19 patients
- Oral paracetamol and/or ibuprofen for treating pain after soft tissue injuries: Single centre double-blind, randomised controlled clinical trial
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.